Cyclin D1, a D-type cyclin regulating G1-phase cell-cycle progression, has been identified as a critical downstream effector of estrogen signaling and is frequently overexpressed in endometrial cancer [33–36]. The gene discussed is CCND1; the disease is endometrial cancer.